Company Update - Promising Result for Ovarian Cancer
Filed with ASX · · 2 pages · English
Earlier from Inoviq
- Preliminary Final Report - Appendix 4E
- Reinstatement to Official Quotation - 20 June 2016
- Suspension from Official Quotation
- Company Update
Later from Inoviq
- Appointment of CEO
- Quarterly Activities Review and Appendix 4C
- Successful Assay Feasibility Results
- Appendix 4D and Half Yearly Reports and Accounts
- Ovarian cancer clinical study results
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq